List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 39 studies with search of: "Drospirenone"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
Conditions: Hypertension;   Postmenopause
Interventions: Drug: drospirenone/17B-estradiol (Angeliq);   Drug: drospirenone/17B-estradiol (Angeliq);   Drug: drospirenone/17B-estradiol (Angeliq);   Drug: drospirenone/17B-estradiol (Angeliq);   Drug: Placebo
2 Completed Efficacy and Safety Study for an Oral Contraceptive Containing Folate
Condition: Oral Contraceptive
Interventions: Drug: Drospirenone/Ethinylestradiol/Methyltetrahydrofolate;   Drug: Drospirenone/Ethinylestradiol (Yaz)
3 Completed SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-Controlled Comparative Study
Condition: Dysmenorrhea
Interventions: Drug: SH T04740B;   Drug: SH T00186DF;   Drug: SH T04740F;   Drug: Placebo
4 Completed A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
Condition: Contraception
Interventions: Drug: BAY86-4891 (Estradiol / Drospirenone);   Drug: BAY86-4891 (Estradiol / Drospirenone)
5 Completed Effects of Angeliq® and Prempro185 on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
Conditions: Pre-Hypertension;   High Blood Pressure
Interventions: Drug: SH K 00641 A - Drospirenone / Estradiol (Angeliq);   Drug: SH K 00641 B - Drospirenone / Estradiol (Angeliq);   Drug: SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM)
6 Completed Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females
Condition: Contraception
Intervention: Drug: Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol
7 Active, not recruiting Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
Condition: Dysmenorrhea
Interventions: Drug: Ethinylestradiol / Drospirenon ( SH TO4740B;   Drug: Ethinylestradiol / Drospirenon ( SH TO4740F);   Drug: Ethinylestradiol / Drospirenon ( SH TOO186DF);   Drug: Ethinylestradiol / Drospirenon
8 Recruiting GA YAZ ACNE in China Phase III
Condition: Acne Vulgaris
Interventions: Drug: EE20/Drospirenone (YAZ, BAY86-5300);   Drug: Placebo
9 Completed Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.
Condition: Healthy
Intervention: Drug: Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131)
10 Recruiting A Study to Examine the Safety and Efficacy Of Drospirenone and Ethinyl Estradiol (YAZ) Compared With Placebo In The Treatment Of Moderate Truncal Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: drospirenone and ethinyl estradiol;   Drug: Placebo tablets
11 Recruiting A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Compared With Placebo In The Treatment Of Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Interventions: Drug: drospirenone and ethinyl estradiol (YAZ);   Drug: Placebo
12 Completed Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)
Condition: Contraception
Interventions: Drug: Estradiol and Nomegestrol Acetate Tablets;   Drug: Drospirenone and Ethinyl Estradiol Tablets
13 Completed Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(COMPLETED)
Condition: Contraception
Interventions: Drug: NOMAC E2;   Drug: drospirenone and ethinyl estradiol tablets
14 Completed Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)
Condition: Contraception
Interventions: Drug: Estradiol and Nomegestrol Acetate Tablets;   Drug: Drospirenone and Ethinyl Estradiol Tablets
15 Completed European Active Surveillance Study (EURAS)
Condition: Contraception
Intervention: Drug: drospirenone/ethinylestradiol
16 Completed Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Condition: Vasomotor Symptoms
Interventions: Drug: Angeliq;   Drug: Placebo
17 Completed Oral Contraceptive and Cardiovascular Risk in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Behavioral: Physical exercise;   Drug: OC - Drospirenone plus Ethynylestradiol;   Dietary Supplement: Vitamin, polyvitamins tablets
18 Recruiting Metabolic Syndrome in PCOS: Precursors and Interventions
Conditions: Polycystic Ovary Syndrome;   Metabolic Syndrome
Interventions: Drug: Metformin;   Drug: flutamide;   Drug: drospirenone;   Other: placebo
19 Recruiting Overweight, Polycystic Ovary Syndrome, and Bone Research Study
Condition: Polycystic Ovary Syndrome
Interventions: Drug: rosiglitazone;   Drug: drospirenone/ethinyl estradiol
20 Recruiting The Oral Contraceptive Pill for Premenstrual Worsening of Depression
Conditions: Premenstrual Syndrome;   Depression
Interventions: Drug: Drospirenone and ethinyl estradiol;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-39)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services